Your browser doesn't support javascript.
loading
Production of biologically active feline interferon beta in insect larvae using a recombinant baculovirus.
Arregui, Mariana Bernadett; Mc Callum, Gregorio Juan; Smith, Ignacio; Villaverde, Marcela Solange; Wolman, Federico Javier; Targovnik, Alexandra Marisa; Miranda, María Victoria.
Afiliação
  • Arregui MB; 1Facultad de Farmacia y Bioquímica, Cátedra de Biotecnología, Universidad de Buenos Aires, Junín 956, 1113 Buenos Aires, Argentina.
  • Mc Callum GJ; 2Instituto de Nanobiotecnología (NANOBIOTEC), CONICET-Universidad de Buenos Aires, Junín 956, 1113 Buenos Aires, Argentina.
  • Smith I; 1Facultad de Farmacia y Bioquímica, Cátedra de Biotecnología, Universidad de Buenos Aires, Junín 956, 1113 Buenos Aires, Argentina.
  • Villaverde MS; 2Instituto de Nanobiotecnología (NANOBIOTEC), CONICET-Universidad de Buenos Aires, Junín 956, 1113 Buenos Aires, Argentina.
  • Wolman FJ; 1Facultad de Farmacia y Bioquímica, Cátedra de Biotecnología, Universidad de Buenos Aires, Junín 956, 1113 Buenos Aires, Argentina.
  • Targovnik AM; 2Instituto de Nanobiotecnología (NANOBIOTEC), CONICET-Universidad de Buenos Aires, Junín 956, 1113 Buenos Aires, Argentina.
  • Miranda MV; 3Unidad de Transferencia Genética, Instituto de Oncología "Ángel H. Roffo", Universidad de Buenos Aires, Av. San Martín 5481, 1417 Buenos Aires, Argentina.
3 Biotech ; 8(8): 341, 2018 Aug.
Article em En | MEDLINE | ID: mdl-30073126
Feline interferon beta is a cytokine that belongs to the type I IFN family, with antitumor, antiviral and immunomodulatory functions. In this work, recombinant feline interferon beta (rFeIFNß) was expressed in insect larvae that constitute important agronomic plagues. rFeIFNß accumulated in the hemolymph of Spodoptera frugiperda larvae infected with recombinant baculovirus and was purified by Blue-Sepharose chromatography directly from larval homogenates on day 4 post-infection. rFeIFNß was recovered after purification with a specific activity of 1 × 106 IU mg-1. By this method, we obtained 8.9 × 104 IU of purified rFeIFNß per larva. The product was biologically active in vitro, with an antiviral activity of 9.5 × 104 IU mL-1, as well as a potent antitumor activity comparable to that of the commercial FeIFNω. The glycosylation of rFeIFNß was confirmed by peptide-N-glycosidase F digestion. Our findings provide a cost-effective platform for large-scale rFeIFNß production in laboratory research or veterinary medicine applications.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: 3 Biotech Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Argentina País de publicação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: 3 Biotech Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Argentina País de publicação: Alemanha